Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-60 of 115 for breast

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery

    Rochester, MN

  2. Infection Outcomes Assessment of Absorbable Antibacterial Soft Tissue Support in Breast Reconstruction

    Rochester, MN

  3. Wearable EEG Headband as a Meditation Device for Breast Cancer Survivors

    Rochester, MN

  4. IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

    Jacksonville, FL

  5. MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma (MelMarT)

    Scottsdale/Phoenix, AZ

  6. Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

    Jacksonville, FL, Scottsdale/Phoenix, AZ

  8. In-home Versus In-Clinic Subcutaneous Nivolumab Administration through Connected and Remote Cancer CARE Beyond Walls

    Jacksonville, FL

  9. ZTE MRI for Visualization of Bone Cement, Breast Biopsy Markers

    Rochester, MN

  10. Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease

    Rochester, MN, Jacksonville, FL

.

Mayo Clinic Footer